Peptio

Browse

Peptide library

Every peptide we have reviewed, with the strongest kind of evidence available for each one and whether any of it comes from human research.

4
catalogued
3
with human evidence
75
sources behind them
Research area
Evidence

  • BPC-157

    BPC 157, PL-14736, PL 14736, PLD-116, PL-10, Bepecin, pentadecapeptide BPC 157

    A 15-amino-acid fragment of a gastric juice protein, studied mostly in rats for tendon and muscle healing. No randomised trial has shown a benefit in people.

    Case reportIn clinical trialsrecovery / performance

  • Retatrutide

    LY3437943, LY-3437943

    Retatrutide is an investigational triple receptor agonist with published phase 3 trials. It is not approved by FDA or EMA, the two regulators checked.

    Human RCTIn clinical trialsweight management

  • TB-500

    TB500, TB 500, Ac-LKKTETQ, TB-500 acetate, thymosin beta-4 fragment 17-23

    A seven-amino-acid fragment of thymosin beta-4, not the protein itself. No study has reported giving it to a human being.

    AnimalNo published human datarecovery / performance

  • Tirzepatide

    LY3298176, Mounjaro, Zepbound

    Tirzepatide is a dual GIP and GLP-1 receptor agonist, approved in the US and the EU for type 2 diabetes and for weight management.

    Human RCTApproved for a medical indicationweight management